A meta-analysis: Do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of...

Area of Science:

• Neuro-oncology
• Clinical Neurology
• Evidence-Based Medicine

Background:

• Seizures are a serious complication of brain tumors.
• Previous studies explored prophylactic antiepileptic drugs (AEDs) to reduce seizure incidence.
• Routine use of AEDs in seizure-naive brain tumor patients remains uncertain.

Purpose of the Study:

• To evaluate the effectiveness of seizure prophylaxis in brain tumor patients.
• To synthesize evidence from randomized trials on AEDs for seizure prevention.

Main Methods:

• A meta-analysis of six randomized controlled trials (RCTs) involving 547 patients.
• Comprehensive literature search across multiple databases (1966-2014).
• Meta-analysis performed using STATA 12.0, calculating Integrated Odd Ratio (OR) and 95% confidence intervals (95%CI).

Main Results:

• Prophylactic antiepileptic interventions did not significantly lower epilepsy incidence compared to control groups (OR=0.939, 95%CI=0.609-1.448).
• Statistical results were robust, with no detected publication bias.
• Analysis included six RCTs with a total of 547 participants.

Conclusions:

• Current integrated evidence does not unequivocally demonstrate benefit from seizure prophylaxis in brain tumor patients.
• Routine administration of AEDs for seizure prevention in this population is not supported by this meta-analysis.
• Further research may be needed to clarify the role of AEDs in brain tumor management.